Aether Industries Limited has informed that its manufacturing site 3 has been commercialized at Plot No. 8202/1, Road No. 8, GIDC Industrial Estate, Sachin, Surat, Gujarat.

The total Capex planned for the site is around Rs. 190 crore of which Rs. 163 crore has been raised from the IPO that was concluded in June 2022 and remaining Rs. 27 crore was funded from internal accruals.

The trial runs have been started off as the facility was kicked off yesterday and the commercial production of the plant will start within the next ten days.

The Manufacturing Site 3 will add capacities to the north of 3,500 MT per annum for production of five new specialty chemicals & intermediates for the pharmaceutical sector.

Aether Industries Limited focuses on producing advanced intermediates and speciality chemicals involving complex and differentiated chemistry and technology core competencies. The company's products find application in the pharmaceutical, agrochemical, material science, coating, high performance photography, additive, and oil and gas segments of the chemical industry.

Our business was started in 2013 with a vision to create a niche in the global chemical industry with a creative approach towards chemistry, technology and systems that would lead to sustainable growth. 

In the first phase of our development through Fiscal 2017, the company focused on building our team and infrastructure and on R&D centred around building core competencies. The revenue generation operations commenced with our second phase in Fiscal 2018. The company claims to be one of the fastest growing specialty chemical companies in India, growing at a CAGR of nearly 60% between Fiscal 2018 and Fiscal 2021.

Production capacity of more than 6,000 MT is available in its state-of-art and DCS automated manufacturing facilities. Aether is also a leading CRAMS (Contract Research and Manufacturing Services) provider and Contract/Exclusive Manufacturing services provider, built upon technology intensive and state-of-art R&D and Pilot Plant facilities. All its R&D, Pilot Plant, CRAMS, and Large Scale Manufacturing facilities are capable of switching between batch and continuous process technology.